A new project, funded in part by Genome British Columbia (Genome BC), will develop strategies to identify children with, or at risk for, Autism Spectrum Disorders (ASDs) much earlier. The project will also help to uncover the underlying causes and pathways of ASDs and define what personalized therapies have the most impact on individual children and why they are successful.

“iTARGET [Individualized Treatments for Autism Recovery using Genetic-Environment Targets] will begin to enable earlier, more accurate diagnoses and personalized treatments for behavioural and bio-medical therapies, which hold tremendous promise for the development of effective medical treatments for ASD,” says Dr. Suzanne Lewis, Investigator, BC Children's Hospital Research Institute; Clinical Professor, Department of Medical Genetics, UBC; and Vice President Research and Chief Medical Officer for the Pacific Autism Family Network (PAFN). 

Read the Genome BC news release for more information.